文献速递慢阻肺哮喘

哮喘与慢阻肺呼吸系统阻抗比较:一项前瞻性观察研究

Comparison of respiratory system impedance in asthma and COPD: A prospective observational study.
PubMed 文献 · Respirology · 2018-01-17

该前瞻性观察研究纳入57例慢阻肺和93例哮喘门诊患者,每6个月检测FEV1和强迫振荡技术(FOT),中位随访26个月。结果显示慢阻肺患者ΔX5更负,且年度变化仅ΔX5在慢阻肺中显著更负;轻度慢阻肺与哮喘相比,入组时阻抗无差异,但ΔX5年变化显著更负。结论提示ΔX5可能有助于慢阻肺气流受限的长期评估。

要点

  • 慢阻肺患者ΔX5较哮喘更负,且年度变化仅ΔX5在慢阻肺中显著更负。
  • 轻度慢阻肺与哮喘入组时呼吸系统阻抗无显著差异。
  • ΔX5可能有助于慢阻肺气流受限的长期评估。

核心结论

  • ΔX5可能有助于慢阻肺气流受限的长期评估。

研究设计与样本

  • 前瞻性观察研究,2013年4月至2013年9月招募慢阻肺或哮喘门诊患者,每6个月检测FEV1和FOT直至2015年9月,年度变化由线性回归曲线斜率估算。
  • 共纳入57例慢阻肺和93例哮喘受试者,中位随访26个月(范围24-29个月)。

主要发现

  • 慢阻肺患者5 Hz与20 Hz平均Rrs差值显著低于哮喘,ΔX5更负。
  • 年度变化中仅ΔX5在慢阻肺较哮喘显著更负。
  • GOLD I/II期慢阻肺与哮喘相比,入组时呼吸系统阻抗无显著差异,但ΔX5年变化在轻度慢阻肺显著更负。

临床怎么用

  • 可利用FOT测量的ΔX5对慢阻肺患者气流受限进行长期随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: A single assessment of within-breath variations of respiratory system reactance (Xrs) at 5 Hz (ΔX5) measured by the forced oscillation technique (FOT) has been reported to be useful for the detection of pathophysiological changes in chronic obstructive pulmonary disease (COPD) and asthma. We examined longitudinal changes in respiratory system resistance (Rrs) and Xrs during tidal breathing between stable asthma and COPD patients in order to clarify the features of changes of respiratory system impedance and airflow limitation for these conditions. METHODS: Between April 2013 and September 2013, outpatients with a COPD or asthma diagnosis were recruited. We examined forced expiratory volume in 1 s (FEV1 ) and FOT every 6 months until September 2015. Annual changes were estimated from the linear regression curve slope. RESULTS: We included 57 and 93 subjects with COPD and asthma, respectively. The median follow-up period was 26 months (range: 24-29 months). Within-breath analysis showed that the difference between mean Rrs at 5 Hz and 20 Hz was significantly lower, and ΔX5 more negative, in COPD than in asthma patients. With regard to annual changes, only ΔX5 was significantly different, more negative, in COPD than in asthma patients. Comparing between COPD subjects of Global Initiative Chronic Obstructive Lung Disease (GOLD) stage I/II and those with asthma, there were no significant differences in respiratory system impedance at enrolment, while annual change in ΔX5 was significantly more negative in mild COPD than in asthma patients. CONCLUSION: ΔX5 may be useful for long-term assessment of airflow limitation in COPD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Kamada T, Kaneko M, Tomioka H, et al. Comparison of respiratory system impedance in asthma and COPD: A prospective observational study. Respirology. 2018. PMID: 29341360. doi:10.1111/resp.13240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。